GlassScriptPhysician profile
Brian D Thornton
NPI 1689625147
$903.62
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $24.00 · 2022: $308 · 2023: $136 · 2024: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $319.61 | 2022-2024 | Mentor Cpx 2 Breast Tissue Expander |
| Mallinckrodt Hospital Products INC. | $149.72 | 2024 | Terlivaz |
| Alexion Pharmaceuticals, INC. | $113.30 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $106.32 | 2019-2023 | Jynarque |
| Baxter Healthcare | $42.87 | 2019 | |
| Ardelyx, INC. | $34.92 | 2023 | Ibsrela |
| Astrazeneca Pharmaceuticals LP | $34.14 | 2022-2023 | Farxiga |
| Glaxosmithkline, LLC. | $29.75 | 2022 | |
| Vifor Pharma, INC. | $24.00 | 2020 | |
| Fresenius USA Marketing, INC. | $20.81 | 2023 | |
| Amgen INC. | $15.03 | 2023 | Tavneos |
| Medical Device Business Services, INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.